Tonight Dr. Miskoff continues talks on the immune system, but this time in regards to monoclonal antibodies (mAb) from a basic and therapeutic standpoint. They are entering many trials with Eli Lilly/NIH/Regeneron and many institutions, countries, and other companies. The…